These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 33855970)

  • 1. Genetic therapies for the first molecular disease.
    Doerfler PA; Sharma A; Porter JS; Zheng Y; Tisdale JF; Weiss MJ
    J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33855970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective therapies for sickle cell disease: are we there yet?
    Crossley M; Christakopoulos GE; Weiss MJ
    Trends Genet; 2022 Dec; 38(12):1284-1298. PubMed ID: 35934593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease.
    Germino-Watnick P; Hinds M; Le A; Chu R; Liu X; Uchida N
    Cells; 2022 Jun; 11(11):. PubMed ID: 35681538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curative approaches for sickle cell disease: A review of allogeneic and autologous strategies.
    Bauer DE; Brendel C; Fitzhugh CD
    Blood Cells Mol Dis; 2017 Sep; 67():155-168. PubMed ID: 28893518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic stem cell collection for sickle cell disease gene therapy.
    Leonard A; Weiss MJ
    Curr Opin Hematol; 2024 May; 31(3):104-114. PubMed ID: 38359264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Therapy as the New Frontier for Sickle Cell Disease.
    Garg H; Tatiossian KJ; Peppel K; Kato GJ; Herzog E
    Curr Med Chem; 2022; 29(3):453-466. PubMed ID: 34047257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease.
    Park SH; Lee CM; Dever DP; Davis TH; Camarena J; Srifa W; Zhang Y; Paikari A; Chang AK; Porteus MH; Sheehan VA; Bao G
    Nucleic Acids Res; 2019 Sep; 47(15):7955-7972. PubMed ID: 31147717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haematopoietic stem cell health in sickle cell disease and its implications for stem cell therapies and secondary haematological disorders.
    Gorur V; Kranc KR; Ganuza M; Telfer P
    Blood Rev; 2024 Jan; 63():101137. PubMed ID: 37919142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy for sickle cell disease.
    Leonard A; Tisdale JF
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):542-547. PubMed ID: 38066927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic stem cell transplantation and cellular therapy in sickle cell disease: where are we now?
    Tanhehco YC; Bhatia M
    Curr Opin Hematol; 2019 Nov; 26(6):448-452. PubMed ID: 31483336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse Approaches to Gene Therapy of Sickle Cell Disease.
    White SL; Hart K; Kohn DB
    Annu Rev Med; 2023 Jan; 74():473-487. PubMed ID: 36067800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell therapy for sickle cell disease: transplantation and gene therapy.
    Walters MC
    Hematology Am Soc Hematol Educ Program; 2005; ():66-73. PubMed ID: 16304361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cas9-AAV6 gene correction of beta-globin in autologous HSCs improves sickle cell disease erythropoiesis in mice.
    Wilkinson AC; Dever DP; Baik R; Camarena J; Hsu I; Charlesworth CT; Morita C; Nakauchi H; Porteus MH
    Nat Commun; 2021 Jan; 12(1):686. PubMed ID: 33514718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current state of gene therapy in sickle cell disease.
    Tang MS; Shan H
    Vox Sang; 2024 Jun; 119(6):521-528. PubMed ID: 38487952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell transplantation in sickle cell disease: therapeutic potential and challenges faced.
    Leonard A; Tisdale JF
    Expert Rev Hematol; 2018 Jul; 11(7):547-565. PubMed ID: 29883237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Genetic Therapy for Sickle Cell Disease.
    Orkin SH; Bauer DE
    Annu Rev Med; 2019 Jan; 70():257-271. PubMed ID: 30355263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease.
    Hoban MD; Orkin SH; Bauer DE
    Blood; 2016 Feb; 127(7):839-48. PubMed ID: 26758916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic strategies for the treatment of sickle cell anaemia.
    Mansilla-Soto J; Rivière I; Sadelain M
    Br J Haematol; 2011 Sep; 154(6):715-27. PubMed ID: 21707580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapies on the horizon for sickle cell disease: a clinician's perspective.
    Butt H; Tisdale JF
    Expert Rev Hematol; 2024 Sep; 17(9):555-566. PubMed ID: 39076056
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.